https://www.moneycontrol.com/news/business/lupin-exploring-demerger-of-api-biz-to-unlock-value-10861591.html
Glenmark Pharma had undergone a similar exercise in May 2019, when it spun off its API business into a new entity called Glenmark Life Sciences, which made its public market debut in August 2021
Create an account or login to join the discussion